Immunoactive polysaccharide functionalized gold nanocomposites promote dendritic cell stimulation and antitumor effects

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Cabuzu D, Cirja A, Puiu R, Grumezescu AM. Biomedical applications of gold nanoparticles. Curr. Top. Med. Chem. 15(16), 1605–1613 (2015).
  Medline CASGoogle Scholar
• 2. Kumar D, Saini N, Jain N, Sareen R, Pandit V. Gold nanoparticles: an era in bionanotechnology. Expert. Opin. Drug Deliv. 10(3), 397–409 (2013).
  Medline CASGoogle Scholar
• 3. Yadav P, Singh SP, Rengan AK, Shanavas A, Srivastava R. Gold laced bio-macromolecules for theranostic application. Int. J. Biol. Macromol. 110, 39–53 (2018).
  Medline CASGoogle Scholar
• 4. Cai Z, Zhang H. Hyaluronan-inorganic nanohybrid materials for biomedical applications. Biomacromolecules 18(6), 1677–1696 (2017).
  Medline CASGoogle Scholar
• 5. Dong XX, Yang JY, Luo L et al. Portable amperometric immunosensor for histamine detection using Prussian blue-chitosan-gold nanoparticle nanocomposite films. Biosens. Bioelectron. 98, 305–309 (2017).
  Medline CASGoogle Scholar
• 6. Regiel-Futyra A, Kus-Liskiewicz M, Sebastian V et al. Development of noncytotoxic chitosan-gold nanocomposites as efficient antibacterial materials. ACS Appl. Mater. Interfaces 7(2), 1087–1099 (2015). • Example of conjugate of AuNP and low-immunogenic polysaccharide.
  Medline CASGoogle Scholar
• 7. Pang G, Wang F, Zhang LW. Dose matters: direct killing or immunoregulatory effects of natural polysaccharides in cancer treatment. Carbohydr. Polym. 195, 243–256 (2018).
  Medline CASGoogle Scholar
• 8. Fu J, Wang Z, Huang L et al. Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi). Phytother. Res. 28(9), 1275–1283 (2014).
  Medline CASGoogle Scholar
• 9. Li X, Qu L, Dong Y et al. A review of recent research progress on the Astragalus genus. Molecules 19(11), 18850–18880 (2014).
  MedlineGoogle Scholar
• 10. Xie JH, Jin ML, Morris GA et al. Advances on bioactive polysaccharides from medicinal plants. Crit. Rev. Food Sci. Nutr. 56, 60–84 (2016).
  Google Scholar
• 11. Jin M, Zhao K, Huang Q, Shang P. Structural features and biological activities of the polysaccharides from Astragalus membranaceus. Int. J. Biol. Macromol. 64(2), 257–266 (2014).
  Medline CASGoogle Scholar
• 12. Ren Q, Zhao S, Ren C, Ma Z. Astragalus polysaccharide alleviates LPS-induced inflammation injury by regulating miR-127 in H9c2 cardiomyoblasts. Int. J. Immunopathol. Pharmacol. 32, 1–11 (2018).
  Google Scholar
• 13. Du X, Chen X, Zhao B et al. Astragalus polysaccharides enhance the humoral and cellular immune responses of hepatitis B surface antigen vaccination through inhibiting the expression of transforming growth factor beta and the frequency of regulatory T cells. FEMS Immunol. Med. Microbiol. 63(2), 228–235 (2011).
  Medline CASGoogle Scholar
• 14. Yin X, Chen L, Liu Y et al. Enhancement of the innate immune response of bladder epithelial cells by Astragalus polysaccharides through upregulation of TLR4 expression. Biochem. Biophys. Res. Commun. 397(2), 232–238 (2010).
  Medline CASGoogle Scholar
• 15. Zhou L, Liu Z, Wang Z et al. Astragalus polysaccharides exerts immunomodulatory effects via TLR4-mediated MyD88-dependent signaling pathway in vitro and in vivo. Sci. Rep. 7, 44822–44835 (2017). •• A good paper for introducing the mechanism of APS for their immunoregulation.
  Medline CASGoogle Scholar
• 16. Wei W, Xiao HT, Bao WR et al. TLR-4 may mediate signaling pathways of Astragalus polysaccharide RAP induced cytokine expression of RAW264.7 cells. J. Ethnopharmacol. 179(8), 243–252 (2016).
  Medline CASGoogle Scholar
• 17. Zhu N, Lv X, Wang Y et al. Comparison of immunoregulatory effects of polysaccharides from three natural herbs and cellular uptake in dendritic cells. Int. J. Biol. Macromol. 93(Pt A), 940–951 (2016).
  Medline CASGoogle Scholar
• 18. Lv X, Chen D, Yang L et al. Comparative studies on the immunoregulatory effects of three polysaccharides using high content imaging system. Int. J. Biol. Macromol. 86(1), 28–42 (2016).
  Medline CASGoogle Scholar
• 19. Banchereau J, Briere F, Caux C et al. Immunobiology of dendritic cells. Annu. Rev. Immunoly. 18(1), 767–811 (2000).
  Medline CASGoogle Scholar
• 20. Garg AD, Vara Perez M, Schaaf M et al. Trial watch: dendritic cell-based anticancer immunotherapy. Oncoimmunology 6(7), 1328341 (2017).
  Google Scholar
• 21. Bol KF, Schreibelt G, Gerritsen WR, De Vries IJ, Figdor CG. Dendritic cell-based immunotherapy: state of the art and beyond. Clin. Cancer Res. 22(8), 1897–1906 (2016). • Good review for introducing dendritic cell-based immunotherapy.
  Medline CASGoogle Scholar
• 22. Anguille S, Smits EL, Bryant C et al. Dendritic cells as pharmacological tools for cancer immunotherapy. Pharmacol. Rev. 67(4), 731–753 (2015).
  Medline CASGoogle Scholar
• 23. Krishnamachari Y, Salem AK. Innovative strategies for co-delivering antigens and CpG oligonucleotides. Adv. Drug. Deliv. Rev. 61(3), 205–217 (2009).
  Medline CASGoogle Scholar
• 24. Iribarren K, Bloy N, Buque A et al. Trial watch: immunostimulation with toll-like receptor agonists in cancer therapy. Oncoimmunology 5(3), 1088631 (2016). •• Good review for introducing the role of TLR agonists in cancer therapy.
  Google Scholar
• 25. Deng S, Zhu S, Qiao Y et al. Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma. Protein Cell 5(12), 899–911 (2014).
  Medline CASGoogle Scholar
• 26. Hussain MA, Shah A, Jantan I et al. One pot light assisted green synthesis, storage and antimicrobial activity of dextran stabilized silver nanoparticles. J. Nanobiotechnol. 12(1), 53–59 (2014). •• A good article for introducing the synthesis procedure of polysaccharide-based nanocomposite.
  MedlineGoogle Scholar
• 27. Bankura K, Maity D, Mollick MM et al. Antibacterial activity of Ag-Au alloy NPs and chemical sensor property of Au NPs synthesized by dextran. Carbohydr. Polym. 107(8), 151–157 (2014).
  Medline CASGoogle Scholar
• 28. Pu X, Ma X, Liu L et al. Structural characterization and antioxidant activity in vitro of polysaccharides from Angelica and Astragalus. Carbohydr. Polym. 137, 154–164 (2016).
  Medline CASGoogle Scholar
• 29. Yang F, Xiao C, Qu J, Wang G. Structural characterization of low molecular weight polysaccharide from Astragalus membranaceus and its immunologic enhancement in recombinant protein vaccine against systemic candidiasis. Carbohydr. Polym. 145, 48–55 (2016).
  Medline CASGoogle Scholar
• 30. Turkevich J, Stevenson PC, Hillier J. A study of the nucleation and growth processes in the synthesis of colloidal gold. Discuss. Faraday Soc. 11(11), 55–75 (1951).
  Google Scholar
• 31. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3(2), 133–146 (2003).
  Medline CASGoogle Scholar
• 32. Pulaski BA, Ostrand-Rosenberg S. Mouse 4T1 breast tumor model. Curr. Protoc. Immunol. Chapter 20 Unit 20 22 (2001).
  Google Scholar
• 33. Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22(1), 745–763 (2004).
  Medline CASGoogle Scholar
• 34. Renaud G, Hamilton RL, Havel RJ. Hepatic metabolism of colloidal gold-low-density lipoprotein complexes in the rat: evidence for bulk excretion of lysosomal contents into bile. Hepatology 9(3), 380–392 (1989).
  Medline CASGoogle Scholar
• 35. Volk-Draper L, Hall K, Griggs C et al. Paclitaxel therapy promotes breast cancer metastasis in a TLR4-dependent manner. Cancer Res. 74(19), 5421–5434 (2014). • Interesting paper reporting the pathway for PTX-induced breast tumor metastasis.
  Medline CASGoogle Scholar
• 36. Chang YS, Jalgaonkar SP, Middleton JD, Hai T. Stress-inducible gene Atf3 in the noncancer host cells contributes to chemotherapy-exacerbated breast cancer metastasis. Proc. Natl Acad. Sci. USA 114(34), 7159–7168 (2017). • A good paper for introducing the possible mechanism of chemotherapy-exacerbated breast cancer metastasis.
  Google Scholar
• 37. Du X, Khan AR, Fu M, Ji J, Yu A, Zhai G. Current development in the formulations of non-injection administration of paclitaxel. Int. J. Pharm. 542(1-2), 242–252 (2018).
  Medline CASGoogle Scholar
• 38. Lu J, Lee-Gabel L, Nadeau MC, Ferencz TM, Soefje SA. Clinical evaluation of compounds targeting PD-1/PD-L1 pathway for cancer immunotherapy. J. Oncol. Pharm. Pract. 21(6), 451–467 (2015).
  Medline CASGoogle Scholar
• 39. Niknam S, Barsoumian HB, Schoenhals JE et al. Radiation followed by OX40 stimulation drives local and abscopal antitumor effects in an anti-PD1-resistant lung tumor model. Clin. Cancer Res. 24(22), 5735–5743 (2018).
  Medline CASGoogle Scholar
• 40. Rech AJ, Dada H, Kotzin JJ et al. Radiotherapy and CD40 activation separately augment immunity to checkpoint blockade in cancer. Cancer Res. 78(15), 4282–4291 (2018).
  Medline CASGoogle Scholar
• 41. Wang S, Campos J, Gallotta M et al. Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8⁺ T cells. Proc. Natl Acad. Sci. USA 113(46), 7240–7249 (2016).
  Google Scholar